A survey on the extent of medication storage and wastage in urban iranian households

Clinical Therapeutics

Volumn 27, Issue 6, 2005, Pages 970-978

  Zargarzadeh, Amir H ^a   Tavakoli, N ^a   Hassanzadeh, A ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Drug consumption; Iran; Pharmacoeconomics; Storage; Wastage

Indexed keywords

ANTIINFECTIVE AGENT; CENTRAL NERVOUS SYSTEM AGENTS; GASTROINTESTINAL AGENT;

ARTICLE; CHRONIC DISEASE; DEMOGRAPHY; DRUG COST; DRUG STORAGE; DRUG USE; DRUG UTILIZATION; FAMILY SIZE; HEALTH SURVEY; HOUSEHOLD; HUMAN; IRAN; MEDICAL INFORMATION; MEDICAL LITERATURE; QUESTIONNAIRE; SOCIOECONOMICS; URBAN AREA; WORK;

EID: 27744525921     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(05)00122-0     Document Type: Article

References (31)

1. IMS Health Web site. Available at: http://www.ims-global. com/insight/insight.htm. Accessed September 20, 2004.
2. Cheraghali M, Solaymani F, Shalviri C. Promoting rational use activities in Iran: A successful trend. Essent Drugs Monit. 2003;33:10-11.
3. World Health Organization. Iran (Islamic Republic of). Available at: http://www.who.int/country/im/en. Accessed September 20, 2004.
4. Iranian Medical Statistics Annual Report. Tehran, Iran: Ministry of Health and Medical Education; 2003.
5. Dinarvand R. A new pharmaceutical environment in Iran: Marketing impacts. Iranian J Pharm Res. 2003;2:1-2. Editorial.
6. Iranian Pharmaceutical Profile. Tehran, Iran: Ministry of Health and Medical Education; 2002.
7. Boivin M. The cost of medication waste. Can Pharm J. 1997; 130:32-39.
8. Cameron S. Study by Alberta pharmacists indicates drug wastage a "mammoth" problem. CMAJ. 1996;155:1596-1598.
9. Thirty eight million British pounds of medicines going to waste. Over The Counter. March 25, 2000:4.
10. Survey finds a fifth of medicines are not taken. Pharm J. 1996;256:148.
11. Laurence DR, Bennett PN. Clinical Pharmacolqy. 6th ed. Singapore: ELBS/Churchill Livingstone; 1987:chap 1.
12. Huge waste of medicines claimed. Pharm J. 2000;264:238-239.
13. Skinner RF, Shave JH, Harris JM, et al. A survey of medicines in patients' homes. Presented at: British Pharmaceutical Conference; September 10-13,1998; Coventry, UK.
14. Ekedahl A, Wergeman L, Rydberg T. Unused drugs in Sweden measured by returns to pharmacies. J Soc Admin Pharm. 2003;20:26-31.
15. Morgan TM. The economic impact of wasted prescription medication in an outpatient population of older adults. J Fam Pract. 2001;50:779-781.
16. Holloway KA, Gautam BR, Reeves BC. The effects of different kinds of user fee on prescribing costs in rural Nepal. Health Policy Plan. 2001;16:421-427.
17. Abou-Auda HS. An economic assessment of the extent of medication use and wastage among families in Saudi Arabia and Arabian Gulf countries. Clin Ther. 2003;25:1276-1292.
18. British National Formulary. London: Royal Pharmaceutical Society; 2002.
19. Isfahan Population Profile. Tehran, Iran: Iranian Organization of Management, Planning and Budget Report; 2002.
20. World Bank. Iran, Islamic Rep. at a glance. Available at: http://www.worldbank.org/data/countrydata/aag/irn_ aag.pdf. Accessed October 12,2004.
21. Too much consumption of medicines threatens Iranian lives [in Persian]. Available at: http://www.bbc.co.uk/persian/iran/ story/2005/02/050207_sm- medicine-abuse.shtml. Accessed March 3, 2005.
22. Daniszewsi R, Langley CA, Marriott JF, Wilson KA. An investigation of medicines returned to general practitioners and community pharmacies. Int J Pharm Pract. 2002;10 (Suppl):R42.
23. Johnson BJ, Muir A, Hudson SA. A search for socio-economic influences in behavior and attitudes to medicines available for self-medication and NHS prescription. Int J Pharm Pract. 2001;9(Suppl):R27.
24. Lapolla M, Stell L. Prescription Medicines and Nursing Homes: A Problem A Solution. Tulsa, Okla: Center for Health Policy Research, Oklahoma State University College of Osteopathic Medicine; 2000:chap 1.
25. Potter M. Medication compliance-a factor in the drug wastage problem. Nurs Times. 1981;77(Suppl 5):17-20.
26. al-Nasser AN. Prescribing patterns in primary healthcare in Saudi Arabia. DICP. 1991;25:90-93.
27. al-Freihi H, Ballal SC, Jaccarini A, et al. Potential for drug misuse in the eastern province of Saudi Arabia. Ann Saudi Med. 1987;7:301-305.
28. Rees JA, Collett JH, Asher DM. Cumulative costs of inadvertent excess prescribing on multiple-item prescriptions forms. Int J Pharm Pract. 1995;3:209-212.
29. Duffin J, Norwood J, Blenkinsopp A. An investigation into medication changes initiated in general practice after patients are discharged from hospital. Pharm J. 1998;261:R32.
30. Zermansky AG. Who controls repeats? Br J Gen Pract. 1996:46:643-647.
31. From compliance to concordance: Achieving shared goals in medicines taking. London, UK: Royal Pharmaceutical Society of Great Britain; 1997.